Connect
← Return to Adverse Heart conditions from Hormone therapy
Discussion
Adverse Heart conditions from Hormone therapy
Prostate Cancer | Last Active: Jul 4 11:49am | Replies (23)Comment receiving replies
It may have been the ADT (Orgovyx) or it may have been the ARPI (Zytiga: Abiraterone).
Of the ADTs tested, Orgovyx was demonstrated to have the least chance of cardiac issues (though the risk was not zero).
Cardiac issues are also a known (but, again small) side-effect of Zytiga. (See attached chart.)
Replies to "It may have been the ADT (Orgovyx) or it may have been the ARPI (Zytiga: Abiraterone)...."
Connect
Yes, we picked Orgovyx for several reasons, to include less cardiac risk . Zytiga can raise BP ( which it did ) which of course didn’t help the aneurysm. It took quite a while after stopping Zytiga for his BP to stabilize. Had to double losartan and add a beta blocker.